Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats

Many neuroprotective agents have been effective in experimental stroke, yet few have translated into clinical application. One reason for this may be failure to consider clinical comorbidities/risk factors in experimental models. We have shown that a naturally occurring interleukin-1 receptor antago...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pradillo, Jesus M, Denes, Adam, Greenhalgh, Andrew D, Boutin, Herve, Drake, Caroline, McColl, Barry W, Barton, Eleanor, Proctor, Spencer D, Russell, James C, Rothwell, Nancy J, Allan, Stuart M
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2012
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434631/
https://ncbi.nlm.nih.gov/pubmed/22781338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2012.101
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge